What does PD-L1 positive or negative mean?
Author:
Affiliation:
1. Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA), Los Angeles, CA 90095
2. Jonsson Comprehensive Cancer Center (JCCC), University of California, Los Angeles (UCLA), Los Angeles, CA 90095
Abstract
Funder
National Cancer Institute
National Institutes of Health
Stand Up To Cancer
American Society of Clinical Oncology
Tower Cancer Research Foundation
The Hope Foundation
UCLA
Publisher
Rockefeller University Press
Subject
Immunology,Immunology and Allergy
Link
http://rupress.org/jem/article-pdf/213/13/2835/1164877/jem_20161462.pdf
Reference47 articles.
1. Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors;Akbay;Cancer Discov.,2013
2. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin’s lymphoma;Ansell;N. Engl. J. Med.,2015
3. PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells;Blank;Cancer Res.,2004
4. MYC regulates the antitumor immune response through CD47 and PD-L1;Casey;Science.,2016
5. Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patients;Cha;Sci. Transl. Med.,2014
Cited by 249 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Immune checkpoint CD161/LLT1‐associated immunological landscape and diagnostic value in oral squamous cell carcinoma;The Journal of Pathology: Clinical Research;2024-01-17
2. C-reactive protein to albumin ratio predict responses to programmed cell death-1 inhibitors in hepatocellular carcinoma patients;World Journal of Gastrointestinal Oncology;2024-01-15
3. Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models;Cell Death & Disease;2024-01-11
4. Enhancing immunogenic responses through CDK4/6 and HIF2α inhibition in Merkel cell carcinoma;Heliyon;2024-01
5. Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors;Molecular Cancer;2023-12-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3